MGP VENTURE FUND III GP, LLC
MGP VENTURE FUND III GP, LLC is a Seed, Series A, Series B and Series C+ fund in the US writing $5M–$15M checks into disruptive-technology, life-sciences, human-health, animal-health, diagnostics, healthcare-it and renewable-energy.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- disruptive-technology, life-sciences, human-health, animal-health, diagnostics, healthcare-it, renewable-energy
- Check size
- $5M–$15M
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2002
- Assets under management
- $300M
- Website
- mtngp.com
Thesis
The fund focuses on investing in disruptive technologies and life sciences, with a particular emphasis on human and animal health, diagnostics, and healthcare IT. MGP Venture Fund III aims to identify and support companies in underserved or underappreciated sectors, leveraging the operational experience of its team to act as "business builders" rather than solely capital providers. The fund targets early-stage companies, including seed, Series A, Series B, and growth equity stages, with a primary geographic scope in North America. The fund closed at $128 million in June 2022. The typical check size ranges from $5 million to $15 million.
Common questions
Does MGP VENTURE FUND III GP, LLC invest at the Seed stage?
Yes. MGP VENTURE FUND III GP, LLC lists Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does MGP VENTURE FUND III GP, LLC write?
MGP VENTURE FUND III GP, LLC writes $5M–$15M checks.
Where does MGP VENTURE FUND III GP, LLC invest?
MGP VENTURE FUND III GP, LLC invests in the US.